170 related articles for article (PubMed ID: 28127508)
1. Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders.
Shu Y; Li H; Zhang L; Wang Y; Long Y; Li R; Qiu W; Lu Z; Hu X; Peng F
Brain Behav; 2017 Jan; 7(1):e00584. PubMed ID: 28127508
[TBL] [Abstract][Full Text] [Related]
2. Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.
Liu C; Xu Y; Cui L; Wang J; Peng B; Zhong L; Chen X
J Clin Neurosci; 2013 Feb; 20(2):278-80. PubMed ID: 23164828
[TBL] [Abstract][Full Text] [Related]
3. Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders.
Li H; Dai Y; Wu AM; Sun X; Lin Y; Lv K; Lu Z
J Neuroimmunol; 2015 Apr; 281():38-43. PubMed ID: 25867466
[TBL] [Abstract][Full Text] [Related]
4. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
5. Chloride imbalance is involved in the pathogenesis of optic neuritis in neuromyelitis optica.
Akaishi T; Takahashi T; Himori N; Takeshita T; Nakazawa T; Aoki M; Nakashima I
J Neuroimmunol; 2018 Jul; 320():98-100. PubMed ID: 29572032
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders.
Yoshikura N; Kimura A; Hayashi Y; Inuzuka T
J Neuroimmunol; 2017 Sep; 310():150-157. PubMed ID: 28756870
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder.
Masuda H; Mori M; Uchida T; Uzawa A; Ohtani R; Kuwabara S
J Neuroimmunol; 2017 Apr; 305():102-107. PubMed ID: 28284329
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid levels and neuromyelitis optica.
Peng F; Zhong X; Deng X; Qiu W; Wu A; Long Y; Hu X; Li Q; Jiang Y; Dai Y
J Neurol; 2010 Jun; 257(6):1021-6. PubMed ID: 20094725
[TBL] [Abstract][Full Text] [Related]
9. Different roles of soluble CD40 ligand in central nervous system damage.
Du L; Chang H; Wei Y; Zhang X; Yin L
Neurol Res; 2020 May; 42(5):372-378. PubMed ID: 32178599
[No Abstract] [Full Text] [Related]
10. Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO.
Min JH; Waters P; Vincent A; Lee S; Y Shin H; H Lee K; Kim BJ
Acta Neurol Scand; 2012 Oct; 126(4):287-91. PubMed ID: 22309305
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis.
Dujmovic I; Pekmezovic T; Obrenovic R; Nikolić A; Spasic M; Mostarica Stojkovic M; Drulovic J
Clin Chem Lab Med; 2009; 47(7):848-53. PubMed ID: 19496733
[TBL] [Abstract][Full Text] [Related]
12. Correlations between serum uric acid level and disease activity, intrathecal inflammation reactivity in patients with multiple sclerosis.
Liu CY; Xu Y; Cui LY; Peng B; Zhong LZ; Chen XW; Wang JM
Chin Med Sci J; 2012 Jun; 27(2):88-91. PubMed ID: 22770406
[TBL] [Abstract][Full Text] [Related]
13. Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder.
Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Aoki R; Kuwabara S
Clin Exp Immunol; 2020 Nov; 202(2):239-248. PubMed ID: 32643149
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder.
Liu B; Zhong X; Lu Z; Qiu W; Hu X; Wang H
Neuroimmunomodulation; 2018; 25(4):185-192. PubMed ID: 30423585
[TBL] [Abstract][Full Text] [Related]
16. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-36 alpha levels are elevated in the serum and cerebrospinal fluid of patients with neuromyelitis optica spectrum disorder and correlate with disease activity.
Song Y; Zhu M; Liu C; Zheng C; Zhou Y; Zhu J; Jin T
Immunobiology; 2019 May; 224(3):397-401. PubMed ID: 30852049
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between the levels and variation of CXCL12, PDGF, CXCL14 in cerebrospinal fluid of optic neuritis and neuromyelitis optica].
Jiang Z; Wei S; Liu Z; Li H; Chen T
Zhonghua Yan Ke Za Zhi; 2015 Dec; 51(12):901-6. PubMed ID: 26888271
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ
Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid uric acid levels associated with disease severity in patients with anti-N-methyl-d-aspartate receptor encephalitis.
Cao B; Li Q; Xiong L; Ruan H; Lu Y; Peng F; Li H; Huang Y; Luo M; Shu Y
J Neuroimmunol; 2023 Nov; 384():578221. PubMed ID: 37864934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
